Winshine Science Co., Ltd. (HK:0209)
:0209
Top Page
Winshine Science Co., Ltd.
(0209)
Select Model
Select Model
Rating:45Neutral
Price Target:
HK$0.24
▲(48.75% Upside)
Action:ReiteratedDate:01/23/26
The score is held down primarily by severe financial weakness (declining revenue/profitability, negative equity, and cash flow stress). Technicals are comparatively supportive with price above key moving averages and positive momentum, but valuation remains unattractive due to ongoing losses and no dividend support.
Positive Factors
Exchange Listing / Access to Capital
A public listing on HKEX provides ongoing access to Hong Kong capital markets and enforces disclosure and governance standards. This structural access supports potential equity or bond raises for recapitalization or restructuring, aiding survival and strategic repositioning over months.
Negative Factors
Negative Shareholders' Equity
Negative equity signals impaired solvency and a weakened capital base, limiting capacity to absorb losses and raising refinancing risk. It constrains access to debt financing, heightens covenant/default risk, and materially reduces strategic flexibility over the coming months.
Read all positive and negative factors
Positive Factors
Negative Factors
Exchange Listing / Access to Capital
A public listing on HKEX provides ongoing access to Hong Kong capital markets and enforces disclosure and governance standards. This structural access supports potential equity or bond raises for recapitalization or restructuring, aiding survival and strategic repositioning over months.
Read all positive factors
Winshine Science Co., Ltd. (0209) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$497.70M
Dividend YieldN/A
Average Volume (3M)7.48M
Price to Earnings (P/E)―
Beta (1Y)0.09
Revenue Growth-7.53%
EPS Growth-93.37%
CountryHK
Employees1,654
SectorConsumer Cyclical
Sector Strength84
IndustryLeisure
Share Statistics
EPS (TTM)-0.17
Shares Outstanding1,485,671,800
10 Day Avg. Volume8,413,762
30 Day Avg. Volume7,476,397
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-0.16
Price to Sales (P/S)0.04
P/FCF Ratio-0.45
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Winshine Science Co., Ltd. Business Overview & Revenue Model
Company Description
Winshine Science Company Limited, an investment holding company, manufactures and trades in hard and stuffed toys in Hong Kong, the People's Republic of China, the United States, Europe, and Korea. The company operates in three segments: Securitie...
How the Company Makes Money
Winshine Science Co., Ltd. generates revenue through a diversified business model that includes the sale of laboratory equipment, diagnostic devices, and medical consumables. The company earns significant income from direct sales to research insti...
Winshine Science Co., Ltd. Financial Statement Overview
Summary
Income Statement
30
Negative
Balance Sheet
20
Very Negative
Cash Flow
15
Very Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 473.15M | 515.91M | 523.26M | 849.10M | 724.63M | 364.31M |
| Gross Profit | -1.30M | 12.80M | 39.27M | 97.88M | 37.26M | 18.52M |
| EBITDA | -33.14M | -28.48M | 5.74M | 36.37M | -95.91M | -73.52M |
| Net Income | -84.76M | -73.03M | -28.65M | 8.08M | -136.01M | -95.78M |
Balance Sheet | ||||||
| Total Assets | 322.50M | 352.88M | 414.32M | 340.95M | 550.35M | 484.69M |
| Cash, Cash Equivalents and Short-Term Investments | 34.13M | 55.26M | 119.33M | 49.77M | 66.63M | 57.90M |
| Total Debt | 231.55M | 219.56M | 243.96M | 195.73M | 276.62M | 235.80M |
| Total Liabilities | 497.94M | 493.37M | 495.19M | 430.59M | 649.29M | 446.79M |
| Stockholders Equity | -173.78M | -139.04M | -80.06M | -89.65M | -98.94M | 37.90M |
Cash Flow | ||||||
| Free Cash Flow | 33.58M | -50.08M | -3.62M | 10.96M | -42.29M | -65.39M |
| Operating Cash Flow | 38.63M | -40.57M | 9.49M | 20.77M | -32.75M | -59.62M |
| Investing Cash Flow | -3.27M | -5.94M | -12.25M | 37.62M | 23.34M | 60.29M |
| Financing Cash Flow | -23.70M | -11.71M | 71.93M | -63.31M | 2.31M | -46.93M |
Winshine Science Co., Ltd. Technical Analysis
Positive
0.16
Price Trends
0.31
Positive
0.25
Positive
0.22
Positive
Market Momentum
>-0.01
Positive
50.37
Neutral
33.63
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0209, the sentiment is Positive. The current price of 0.16 is below the 20-day moving average (MA) of 0.37, below the 50-day MA of 0.31, and below the 200-day MA of 0.22, indicating a neutral trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 50.37 is Neutral, neither overbought nor oversold. The STOCH value of 33.63 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:0209.
Winshine Science Co., Ltd. Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | HK$163.00M | 4.03 | -42.82% | ― | -6.48% | -38.10% | |
51 Neutral | HK$41.73M | -16.67 | -1.47% | ― | 0.47% | -195.45% | |
47 Neutral | HK$275.68M | -5.54 | -50.25% | ― | -61.76% | 75.15% | |
45 Neutral | HK$497.70M | -0.15 | 54.19% | ― | -7.53% | -93.37% | |
42 Neutral | HK$139.90M | -2.22 | -18.16% | ― | 84.26% | 44.41% | |
40 Neutral | HK$125.05M | -8.78 | -41.62% | ― | -13.96% | 64.58% |
* Consumer Cyclical Sector Average
HK:0209
Winshine Science Co., Ltd.
0.34
0.22
188.79%
HK:1348
Quali-Smart Holdings Ltd.
0.19
0.13
211.67%
HK:3830
Kiddieland International Ltd.
0.16
0.13
409.38%
HK:6918
Kidztech Holdings Ltd.
0.16
0.04
35.59%
HK:0765
Perfectech International Holdings Limited
0.26
-0.10
-28.17%
HK:8545
Amuse Group Holding Ltd.
0.04
>-0.01
-12.50%
Winshine Science Co., Ltd. Corporate Events
Winshine Science Proposes Name Change to Poly Xverse and Seeks Fresh Capital Mandates
Jan 30, 2026
Winshine Science Company Limited plans to rebrand itself as Poly Xverse Intelligent Technology Co. Ltd, adopting a new Chinese name as well, in a move that signals a strategic repositioning toward intelligent technology and a refreshed corporate i...
Winshine Science Raises HK$176.5 Million Through Fully Subscribed Rights Issue
Jan 15, 2026
Winshine Science Company Limited has completed a fully underwritten rights issue of 1,299,962,832 new shares on the basis of seven rights shares for every one existing share, raising estimated net proceeds of approximately HK$176.5 million. Valid ...
Winshine Science Moves to Ease Going Concern Pressure with Rights Issue and Cost Cuts
Dec 31, 2025
Winshine Science Company Limited has outlined further measures to address a going concern disclaimer raised in its latest annual report, focusing on improving liquidity and strengthening its financial position. The company has launched a substanti...
Winshine Science Approves Significant Rights Issue at SGM
Dec 5, 2025
Winshine Science Company Limited, a firm incorporated in Bermuda, held a Special General Meeting (SGM) on December 5, 2025, where a proposed Rights Issue was approved by independent shareholders. The resolution passed with 73.21% of votes in favor...
Winshine Science Co., Ltd. Announces Special General Meeting for Rights Issue
Nov 13, 2025
Winshine Science Co., Ltd. has announced a Special General Meeting to be held on December 5, 2025, to discuss and vote on a proposed Rights Issue. The Rights Issue involves the allotment of over 1.29 billion new shares at a subscription price of H...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.